Literature DB >> 7573199

Nephrotic syndrome, malignant thymoma, and myasthenia gravis. Case report and review of the literature.

S D Jayasena1, R G Woolfson, M H Griffiths, G H Neild.   

Abstract

We describe a patient with nephrotic syndrome due to focal-segmental glomerulosclerosis, occurring 3 years after thymectomy and myasthenia gravis. Nine other cases of nephrotic syndrome associated with thymoma and myasthenia gravis reported in the literature are reviewed. The nephrotic syndrome may be due to T cell dysfunction associated with thymoma; however, animal models suggest that genetic factors may also be involved.

Entities:  

Mesh:

Year:  1995        PMID: 7573199     DOI: 10.1159/000168865

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  4 in total

1.  Nephrotic syndrome associated with metastatic thymoma treated with chemotherapy.

Authors:  Shin Hye Yoo; Hyean-Ji Kim; Jeong-Han Kim; Gyeong-Won Lee; Jeong Hee Lee; Se Hyun Kim; Ji-Won Kim; Jin Won Kim; Jeong-Ok Lee; Yu Jung Kim; Keun-Wook Lee; Jee Hyun Kim; Soo-Mee Bang; Jong Seok Lee
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

2.  Secondary membranous nephropathy in a patient with myasthenia gravis without thymic disease, and partial remission induced by adrenocorticotropic hormone therapy.

Authors:  Ramy M Hanna; Farid Arman; Umut Selamet; William D Wallace; Marina Barsoum; Anjay Rastogi; Niloofar Nobakht; Perry Shieh
Journal:  SAGE Open Med Case Rep       Date:  2019-08-08

3.  Nephrotic syndrome after thymectomy for myasthenia gravis.

Authors:  V B Kute; P R Shah; J D Shrimali; M R Gumber; H V Patel; A V Vanikar; H L Trivedi
Journal:  Indian J Nephrol       Date:  2013-01

4.  Nephrotic Syndrome and a Retroperitoneal Mass: A Case Report of a Patient with Recurrent Invasive Thymoma.

Authors:  Hiroaki Myoga; Tetsu Akimoto; Naoko Mato; Takakiyo Nakaya; Takuya Murakami; Hiromichi Yoshizawa; Saki Nakagawa; Atsushi Miki; Takahiro Masuda; Takahisa Kobayashi; Yuko Ono; Osamu Saito; Yoshihiko Ueda; Shigeaki Muto; Daisuke Nagata
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.